elfabrio
chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry sykdom - andre alimentary tract and metabolism products, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).
nicotinell 2 mg
haleon denmark aps - nikotinpolakrilin - medisinsk tyggegummi med icemintsmak - 2 mg
nicotinell 4 mg
haleon denmark aps - nikotinpolakrilin - medisinsk tyggegummi med icemintsmak - 4 mg
nicotinell 2 mg
haleon denmark aps - nikotinpolakrilin - medisinsk tyggegummi med spearmintsmak - 2 mg
nicotinell 4 mg
haleon denmark aps - nikotinpolakrilin - medisinsk tyggegummi med spearmintsmak - 4 mg
nicotinell 2 mg
haleon denmark aps - nikotinpolakrilin - medisinsk tyggegummi med tropisk fruktsmak - 2 mg
nicotinell 4 mg
haleon denmark aps - nikotinpolakrilin - medisinsk tyggegummi med tropisk fruktsmak - 4 mg
nicotinell 21 mg/24 timer
haleon denmark aps - nikotin - depotplaster - 21 mg/24 timer
nicotinell 7 mg/24 timer
haleon denmark aps - nikotin - depotplaster - 7 mg/24 timer
nicotinell 14 mg/24 timer
haleon denmark aps - nikotin - depotplaster - 14 mg/24 timer